Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study.
Graf H, Fast S, Pacini F, Pinchera A, Leung A, Vaisman M, Reiners C, Wemeau JL, Huysmans D, Harper W, Driedger A, de Souza HN, Castagna MG, Antonangeli L, Braverman L, Corbo R, Düren C, Proust-Lemoine E, Edelbroek MA, Marriott C, Rachinsky I, Grupe P, Watt T, Magner J, Hegedus L.
Graf H, et al. Among authors: vaisman m.
J Clin Endocrinol Metab. 2011 May;96(5):1368-76. doi: 10.1210/jc.2010-1193. Epub 2011 Feb 23.
J Clin Endocrinol Metab. 2011.
PMID: 21346067
Clinical Trial.